---
figid: PMC4767244__nov26503
figtitle: NFKB signaling by oncogenic pathways in GBM
organisms:
- NA
pmcid: PMC4767244
filename: nov26503.jpg
figlink: /pmc/articles/PMC4767244/figure/NOV265F3/
number: F3
caption: Modulation of NF-κB signaling by oncogenic pathways in GBM. The link between
  the primary oncogenic pathways active in GBM and the NF-κB system are illustrated.
  Oncogenic pathways are shaded in red and tumor suppressor pathways in blue. The
  RTKs, EGFR and PDGFR, induce NF-κB activation via a number of interrelated pathways,
  and a reciprocal relationship between EGFR amplification and NFKB1A deletion is
  seen. Loss of tumor suppressors such as PTEN, NF1, and ARF promote NF-κB activity
  because of their physiological role in attenuating the NF-κB response. The p53 pathway
  is a tumor suppressor response modified in virtually all GBMs. A reciprocal association
  between p53 and NF-κB signaling is evident at multiple pre- and postnuclear translocational
  points. In addition to cell-intrinsic responses, the inflammatory GBM microenvironment
  contributes to high NF-κB activity by triggering canonical and noncanonical signaling.
papertitle: 'Nuclear factor-κB in glioblastoma: insights into regulators and targeted
  therapy.'
reftext: Kirk E. Cahill, et al. Neuro Oncol. 2016 Mar;18(3):329-339.
year: '2016'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9819323
figid_alias: PMC4767244__F3
figtype: Figure
organisms_ner:
- Homo sapiens
- Drosophila melanogaster
redirect_from: /figures/PMC4767244__F3
ndex: 5a866850-debb-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4767244__nov26503.html
  '@type': Dataset
  description: Modulation of NF-κB signaling by oncogenic pathways in GBM. The link
    between the primary oncogenic pathways active in GBM and the NF-κB system are
    illustrated. Oncogenic pathways are shaded in red and tumor suppressor pathways
    in blue. The RTKs, EGFR and PDGFR, induce NF-κB activation via a number of interrelated
    pathways, and a reciprocal relationship between EGFR amplification and NFKB1A
    deletion is seen. Loss of tumor suppressors such as PTEN, NF1, and ARF promote
    NF-κB activity because of their physiological role in attenuating the NF-κB response.
    The p53 pathway is a tumor suppressor response modified in virtually all GBMs.
    A reciprocal association between p53 and NF-κB signaling is evident at multiple
    pre- and postnuclear translocational points. In addition to cell-intrinsic responses,
    the inflammatory GBM microenvironment contributes to high NF-κB activity by triggering
    canonical and noncanonical signaling.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - TNFRSF1A
  - EGFR
  - PDGFRB
  - PDGFRA
  - NUMBL
  - BIRC2
  - TRAF1
  - TRAF2
  - TRAF3
  - TRAF4
  - TRAF5
  - TRAF6
  - TRAF7
  - GAB1
  - PIGU
  - AGFG1
  - RIPK1
  - DCAF1
  - RPAIN
  - PTPN11
  - NF1
  - CYLD
  - PRRT2
  - PRKCA
  - PRKCB
  - PRKCD
  - PRKCE
  - PRKCG
  - PRKCH
  - PRKCI
  - PRKCQ
  - PRKCZ
  - PRKD3
  - MAPKAP1
  - MTOR
  - RICTOR
  - MLST8
  - PTEN
  - IKBKG
  - MDM2
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - CDKN2A
  - KRAS
  - HRAS
  - NRAS
  - CHUK
  - IKBKB
  - RPS6KA1
  - RPS6KA2
  - RPS6KA3
  - RPS6KA4
  - RPS6KA5
  - RPS6KA6
  - AKT1
  - AKT2
  - AKT3
  - NFKB1
  - RELA
  - RELB
  - REL
  - NFKB2
  - TP53
  - TP63
  - TP73
  - ATM
  - ERC1
  - SYT1
  - GORASP1
  - WNK1
  - ING4
  - CD40
  - ARHGEF7
  - ASCC1
  - H3P40
  - Egfr
  - Traf6
  - Traf4
  - dos
  - rip
  - ripp
  - csw
  - Nf1
  - inaC
  - Pkc98E
  - aPKC
  - Pkc53E
  - Pten
  - nmo
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Arl1
  - Arf1
  - Arl2
  - ras
  - Ras64B
  - Ras85D
  - IKKbeta
  - Akt
  - Dif
  - dl
  - Rel
  - p53
  - betaTub60D
  - hth
  - tefu
  - wash
  - Hrb27C
  - Rpt5
  - DCTN2-p50
  - Cancer
  - Lung cancer
---
